These antibody isotypes have enhanced affinity for the FcγRIIIA (CD16) due to a-fucosylated FC glycans, which results in rapid reduction of platelets leading to significant thrombocytopenia (44, 45). This evidence concerns the gene FCGR3A and Thrombocytopenia.